Cargando…

Effects of a short-term alirocumab administration on the aortic stiffness: preliminary results

Detalles Bibliográficos
Autores principales:	Mauro, Feola, Cinzia, Ferreri, Arianna, Rossi, Marzia, Testa, Gaetano, Ruocco, Tassone, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2019
Materias:	Letter To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828600/ https://www.ncbi.nlm.nih.gov/pubmed/31700518 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.10.001

Ejemplares similares

The Analysis of Arterial Stiffness in Heart Failure Patients: The Prognostic Role of Pulse Wave Velocity, Augmentation Index and Stiffness Index
por: Anastasio, Fabio, et al.
Publicado: (2022)

The Analysis of Arterial Stiffness in Heart Failure Patients in Comparison with Healthy Subjects and Patients with Cardiovascular Risk Factors
por: Feola, Mauro, et al.
Publicado: (2019)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
por: Feola, Mauro, et al.
Publicado: (2020)

Correction: Feola, M., et al. Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation. J. Clin. Med. 2020, 9, 2932
por: Feola, Mauro, et al.
Publicado: (2021)

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure †
por: Testa, Marzia, et al.
Publicado: (2018)

Role of (123)I-Iobenguane Myocardial Scintigraphy in Predicting Short-term Left Ventricular Functional Recovery: An Interesting Image
por: Feola, Mauro, et al.
Publicado: (2015)

Usefulness of a Telemedicine Program in Refractory Older Congestive Heart Failure Patients
por: Burdese, Emanuela, et al.
Publicado: (2018)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

In-hospital Routes of Acute Heart Failure Admissions During COVID-19
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Echocardiography and impedance cardiography as determinants of successful slow levosimendan infusion in advanced older heart failure patients
por: Ruocco, Gaetano, et al.
Publicado: (2021)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients
por: Leto, Laura, et al.
Publicado: (2015)

Different Renal Function Patterns in Patients With Acute Heart Failure: Relationship With Outcome and Congestion
por: Palazzuoli, Alberto, et al.
Publicado: (2022)

The influence of arterial stiffness in heart failure: a clinical review
por: Feola, Mauro
Publicado: (2021)

An Update on the Role of Arterial Stiffness in Heart Failure and the Treatment of Dyslipidemia
por: Feola, Mauro
Publicado: (2023)

Fatal Recurrent Staphylococcus aureus Infection in a Patient With an Aortic Endostent Under Alirocumab
por: Stöllberger, Claudia, et al.
Publicado: (2019)

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES
por: Jukema, J. Wouter, et al.
Publicado: (2019)

Short-term changes of blood pressure and aortic stiffness in older patients after transcatheter aortic valve implantation
por: Goudzwaard, Jeannette A, et al.
Publicado: (2019)

Prognostic factors of mid-term clinical outcome in congestive heart failure patients discharged after acute decompensation
por: Feola, Mauro, et al.
Publicado: (2012)

RE: Praluent (Alirocumab)-Induced Renal Injury
por: Rosenson, Robert S., et al.
Publicado: (2017)

Mortality Benefit of Alirocumab: A Bayesian Perspective
por: Labos, Christopher, et al.
Publicado: (2019)

Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)
por: East, Cara, et al.
Publicado: (2022)

Aortic Stiffness and Diastolic Dysfunction in Sprague Dawley Rats Consuming Short-Term Fructose Plus High Salt Diet
por: Komnenov, Dragana, et al.
Publicado: (2020)

Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
por: Gao, Fei, et al.
Publicado: (2022)

Alirocumab in Post ACS Patients - Saving Lives at a Premium
por: George, Melvin, et al.
Publicado: (2022)

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab
por: McDonagh, Marian, et al.
Publicado: (2016)

Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients
por: Feola, Mauro, et al.
Publicado: (2016)

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans
por: Reyes-Soffer, Gissette, et al.
Publicado: (2017)

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
por: Ginsberg, Henry N., et al.
Publicado: (2019)

Exposure to alirocumab during the first trimester of pregnancy: A case report
por: Vuignier, Yann, et al.
Publicado: (2021)

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
por: Steffens, Daniel, et al.
Publicado: (2021)

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats
por: Huang, Hui-Chun, et al.
Publicado: (2022)

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
por: Pérez de Isla, Leopoldo, et al.
Publicado: (2023)

Relationship between Cognitive Function, Depression/Anxiety and Functional Parameters in Patients Admitted for Congestive Heart Failure
por: Feola, Mauro, et al.
Publicado: (2013)

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
por: Kühnast, Susan, et al.
Publicado: (2014)

Safety and efficacy of alirocumab: A meta analysis of 12 randomized controlled trials
por: Shukla, Ajay K., et al.
Publicado: (2019)

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
por: White, Harvey D, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bbei47qqv345rotb8c22rtv9t6